 |
|
The Preoperative Bleeding Time Test Lacks Clinical Benefit
College of American Pathologists' and American Society of Clinical Pathologists' Position Article
Powers Peterson, MD;
Timothy E. Hayes, MD, DVM;
Charles F. Arkin, MD;
Edwin G. Bovill, MD;
Robert B. Fairweather, MD;
William A. Rock, Jr, MD;
Douglas A. Triplett, MD;
John T. Brandt, MD
Arch Surg. 1998;133:134-139.
The major conclusions of this position article are as follows: (1) In the absence of a history of a bleeding disorder, the bleeding time is not a useful predictor of the risk of hemorrhage associated with surgical procedures. (2) A normal bleeding time does not exclude the possibility of excessive hemorrhage associated with invasive procedures. (3) The bleeding time cannot be used to reliably identify patients who may have recently ingested aspirin or nonsteroidal anti-inflammatory agents or those who have a platelet defect attributable to these drugs. The best preoperative screen to predict bleeding continues to be a carefully conducted clinical history that includes family and previous dental, obstetric, surgical, traumatic injury, transfusion, and drug histories. A history suggesting a possible bleeding disorder may require further evaluation; such an evaluation may include performance of the bleeding time test, as well as a determination of the platelet count, the prothrombin time, and the activated partial thromboplastin time. In the absence of a history of excessive bleeding, the bleeding time fails as a screening test and is, therefore, not indicated as a routine preoperative test.
From the Departments of Pathology, Cornell University Medical College, New York, NY (Dr Peterson); Maine Medical Center, Portland (Dr Hayes); University of Vermont College of Medicine, Burlington (Dr Bovill); Dartmouth-Hitchcock Medical Center, Lebanon, NH (Dr Fairweather); University of Mississippi Medical Center, Jackson (Dr Rock); Ball Memorial Hospital, Muncie, Ind (Dr Triplett); and Ohio State University College of Medicine, Columbus (Dr Brandt); and the Department of Laboratory Medicine, Boston University Medical Center, Boston, Mass (Dr Arkin). Dr Peterson is now with the Department of Pathology and Laboratory Medicine, Medical College of Pennsylvania and Hahnemann University School of Medicine, Allegheny University of the Health Sciences, Philadelphia.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The value of post-biopsy ultrasound in predicting complications after percutaneous renal biopsy of native kidneys
Waldo et al.
Nephrol Dial Transplant 2009;24:2433-2439.
ABSTRACT
| FULL TEXT
Dr William W. Duke: Pioneer in Platelet Research
Kickler
JAMA 2009;301:2267-2269.
FULL TEXT
Is it necessary to stop antiplatelet agents before a native renal biopsy?
Mackinnon et al.
Nephrol Dial Transplant 2008;23:3566-3570.
ABSTRACT
| FULL TEXT
How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults
Kamal et al.
Mayo Clin Proc. 2007;82:864-873.
ABSTRACT
| FULL TEXT
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
The Society of Thoracic Surgeons Blood Conservatio et al.
Ann. Thorac. Surg. 2007;83:S27-S86.
ABSTRACT
| FULL TEXT
Evaluation of Prolonged aPTT Values in the Pediatric Population
Shah et al.
CLIN PEDIATR 2006;45:347-353.
ABSTRACT
Brief Communication: Duration of Platelet Dysfunction after a 7-Day Course of Ibuprofen
Goldenberg et al.
ANN INTERN MED 2005;142:506-509.
ABSTRACT
| FULL TEXT
Possible Interaction Between Sevoflurane and Aloe vera
Lee et al.
The Annals of Pharmacotherapy 2004;38:1651-1654.
ABSTRACT
| FULL TEXT
Screening for the Risk for Bleeding or Thrombosis
Eckman et al.
ANN INTERN MED 2003;138:W-15-W-24.
ABSTRACT
| FULL TEXT
Effects of PEG-Hirudin in Clotting Parameters and Platelet Function and its Interaction with Aspirin in Healthy Volunteers
Esslinger et al.
CLIN APPL THROMB HEMOST 2003;9:79-88.
ABSTRACT
Laboratory Screening for Abnormalities of Primary Hemostasis: What's Next?
Lippi and Franchini
Clin. Chem. 2001;47:2071-2071.
FULL TEXT
Discontinuation of the Bleeding Time Test without Detectable Adverse Clinical Impact
Lehman et al.
Clin. Chem. 2001;47:1204-1211.
ABSTRACT
| FULL TEXT
A Novel Synthetic Inhibitor of Factor Xa Decreases Early Reocclusion and Improves 24-h Patency after Coronary Fibrinolysis in Dogs
Abendschein et al.
J. Pharmacol. Exp. Ther. 2001;296:567-572.
ABSTRACT
| FULL TEXT
Effects of nabumetone compared with naproxen on platelet aggregation in patients with rheumatoid arthritis
Knijff-Dutmer et al.
Ann Rheum Dis 1999;58:257-259.
ABSTRACT
| FULL TEXT
|
